Clinical Trials Directory

Trials / Completed

CompletedNCT01232231

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus in the Outpatient Setting: a Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Joseph Kim · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effectiveness of topical and oral antibiotics in eliminating carriage of methicillin-resistant Staphylococcus aureus (MRSA) among those living in the community. We hypothesize that a greater proportion of those who receive intervention will eliminate MRSA carriage compared to those who do not receive any intervention.

Conditions

Interventions

TypeNameDescription
DRUGpharmacological decolonization treatmentChlorhexidine gluconate 4% body scrub and 2% shampoo daily PLUS mupirocin 2%, fusidic acid 2%, or chlorhexidine gluconate 0.2% intranasally bid PLUS trimethoprim-sulfamethoxazole 160/800mg po bid or doxycycline 100mg po bid all for 7 days
BEHAVIORALEducationNo pharmacological decolonization treatment but given education regarding personal hygiene and environmental cleaning

Timeline

Start date
2010-07-01
Primary completion
2012-04-01
Completion
2012-11-01
First posted
2010-11-02
Last updated
2013-02-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01232231. Inclusion in this directory is not an endorsement.